Atlas Trials

Psychosis Associated With Alzheimer's Disease

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Psychosis Associated With Alzheimer's Disease

RecordFirmDate
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis (NCT07459660)MapLight Therapeutics2026-03-25
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis (NCT06887192)MapLight Therapeutics2025-08-15
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease (NCT06540833)Intra-Cellular Therapies, Inc.2024-08-15
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) (NCT06126224)Karuna Therapeutics, Inc., a Bristol Myers Squibb company2023-08-28
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) (NCT05980949)Karuna Therapeutics, Inc., a Bristol Myers Squibb company2023-07-11
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) (NCT05511363)Karuna Therapeutics, Inc., a Bristol Myers Squibb company2022-08-23

Track Psychosis Associated With Alzheimer's Disease automatically

Every clearance here is in the API, with alerts when new ones post.